Abstract:Vancomycin-functionalized micro- or nanoparticles are frequently used for isolation and enrichment of bacteria from various samples. Theoretically, only Gram-positive organisms should adhere to the functionalized surfaces as vancomycin is an antibiotic targeting a peptidoglycan precursor in the cell wall, which in Gram-negative bacteria is shielded by the outer cell membrane. In the literature, however, it is often reported that Gram-negative bacteria also bind efficiently to the vancomycin-modified particles. The goal of our study was to identify the underlying cause for these different findings. For each species several strains, including patient isolates, were investigated, and effects such as day-to-day reproducibility, particle type, and the antimicrobial effect of vancomycin-coupled beads were explored. Overall, we found that there is a strong preference for binding Gram-positive organisms, but the specific yield is heavily influenced by the strain and experimental conditions. For Staphylococcus aureus average yields of approximately 100% were obtained. Respectively, yields of 44% for Staphylococcus cohnii , 22% for Staphylococcus warneri , 17% for Enterococcus faecalis and 5% for vancomycin-sensitive Enterococcus faecium were found Yields for Gram-negative species ( Escherichia coli , Klebsiella pneumoniae , Acinetobacter baumannii ) and vancomycin-resistant Enterococcus faecium were below 3%. Our results indicate that the interaction between vancomycin and the D -alanine- D -alanine terminus of the peptidoglycan precursor in the bacterial cell wall is the dominant force responsible for the adherence of the bacteria to the particle surface. It needs to be considered though, that other factors, such as the specific molecules presented on the bacterial surface, as well as the pH, and the ion concentrations in the surrounding medium will also play a role, as these can lead to attractive or repulsive electrostatic forces. Last but not least, when using colony forming unit-based quantification for determining the yields, the influence of cell cluster formation and different sensitivities towards the antimicrobial effect of the vancomycin beads between species and strains needs to be considered.

AFFINITY ADSORBENTS WITH D-ALANINE AND D,L-ALANINE AS LIGANDS FOR VANCOMYCIN GROUP ANTIBIOTICS

Conformational Studies Of Resin-Bound Vancomycin And The Complex Of Vancomycin And Ac-2-L-Lys-D-Ala-D-Ala

Crystal structure of vancomycin bound to the resistance determinant d-alanine-d-serine

Study on Antibody Adsorption and Elution Performance of Carboxyl and Hydrophobic Groups on Mixed-Mode Ligands

Modification of Vancomycin Structure to Combat against Emerging Vancomycin Resistance

A Biochemical Lanthanide-Encoding Approach Enables Quantitative Monitoring of the Bacterial Response to Vancomycin Treatment.

Separation and structural characterization of unknown impurity in vancomycin by two-dimensional preparative liquid chromatography, LC-MS and NMR

Solid-phase Synthesis and Antibacterial Evaluations of N-demethylvancomycin Derivatives

Evaluating the potential of vancomycin-modified magnetic beads as a tool for sample preparation in diagnostic assays

Design and Synthesis of Macrocycles Active Against Vancomycin-Resistant Enterococci (VRE): the Interplay Between D-Ala-d-lac Binding and Hydrophobic Effect

Single Amine or Guanidine Modification on Norvancomycin and Vancomycin to Overcome Multidrug-Resistance through Augmented Lipid II Binding and Increased Membrane Activity

Synthesis and Antibacterial Evaluation of Novel Vancomycin Derivatives Containing Quaternary Ammonium Moieties

Enhancing the antibacterial efficacy of vancomycin analogues: targeting metallo-β-lactamases and cell wall biosynthesis

Improved Chiral Separation Of Amino Acid Derivatives By Capillary Electrophoresis With Vancomycin As Chiral Selector

Antibacterial Activity of Vancomycin Encapsulated in Poly(DL-lactide-co-glycolide) Nanoparticles Using Electrospraying

Vancomycin-Polyguanidino Dendrimer Conjugates Inhibit Growth of Antibiotic-Resistant Gram-Positive and Gram-Negative Bacteria and Eradicate Biofilm-Associated S. aureus

Design, Synthesis, And Antibacterial Activity Of Demethylvancomycin Analogues Against Drug-Resistant Bacteria

Identification of Synthetic Compounds Active Against Vre: the Role of the Lipidated Aminoglucose and the Structure of Glycopeptide Binding Pocket

Analysis of the homodimeric structure of a D‐Ala‐D‐Ala metallopeptidase, VanX, from vancomycin‐resistant bacteria

Alendronate-decorated biodegradable polymeric micelles for potential bone-targeted delivery of vancomycin

Fluorimetric monitoring of vancomycin using an allosteric probe-initiated sensing platform